investorscraft@gmail.com

Stock Analysis & ValuationKalaris Therapeutics Inc (KLRS)

Previous Close
$5.46
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

139 Main Street, Suite 500
Cambridge, MA 02142
United States
Industry: Biotechnology
Sector: Healthcare
CEO: Andrew Oxtoby
Full Time Employees: 14

Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

HomeMenuAccount